| 1. |
Flynn CD, Tran L, Reid CM, et al. Bi-national outcomes of redo surgical aortic valve replacement in the era of valve-in-valve transcatheter aortic valve[J]. Heart Lung Circ, 2024, 33(10): 1432-1438.
|
| 2. |
Narayan P, Dimagli A, Fudulu DP, et al. Risk factors and outcomes of reoperative surgical aortic valve replacement in the United Kingdom[J]. Ann Thorac Surg, 2023, 116(4): 759-766.
|
| 3. |
Dokollari A, Cameli M, Mandoli GE, et al. Early and midterm clinical outcomes of transcatheter valve-in-valve implantation versus redo surgical aortic valve replacement for aortic bioprosthetic valve degeneration: two faces of the same medal[J]. J Cardiothorac Vasc Anesth, 2021, 35(11): 3223-3231.
|
| 4. |
Hahn RT, Webb J, Pibarot P, et al. 5-year follow-up from the PARTNER 2 aortic valve-in-valve registry for degenerated aortic surgical bioprostheses[J]. JACC Cardiovasc Interv, 2022, 15(7): 698-708.
|
| 5. |
Yousef S, Serna-gallegos D, Iyanna N, et al. Valve-in-valve transcatheter aortic valve replacement versus isolated redo surgical aortic valve replacement[J]. J Thorac Cardiovasc Surg, 2024, 168(4): 1003-1010.
|
| 6. |
Walther T, Kempfert J, Borger MA, et al. Human minimally invasive off-pump valve-in-a-valve implantation[J]. Ann Thorac Surg, 2008, 85(3): 1072-1073.
|
| 7. |
Ye J, Lee AJ, Blanke P, et al. The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction[J]. Catheter Cardiovasc Interv, 2018, 92(6): 1209-1214.
|
| 8. |
Nappi F. Advancements and challenges in the management of prosthetic valve endocarditis: a review[J/OL]. Pathogens, 2024, 13(12): 1039. DOI: 10.3390/pathogens13121039 .
|
| 9. |
Raschpichler M, De Waha S, Holzhey D, et al. Valve‐in‐valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement for failed surgical aortic bioprostheses: a systematic review and meta-analysis[J/OL]. J Am Heart Assoc, 2022, 11(24): e7965. DOI: 10.1161/JAHA.121.024848.
|
| 10. |
張韶鵬, 趙豐, 白云鵬, 等. 經導管瓣中瓣技術治療外科生物瓣衰敗的單中心回顧性研究[J]. 中國胸心血管外科臨床雜志, 2024, 31(6): 842-847.Zhang SP, Zhao F, Bai YP, et al. Transcatheter valve-in-valve aortic valve replacement for degenerated aortic surgicalbioprostheses: a retrospective study in a single center[J]. Chin J Clin Thorac Cardiovasc Surg, 2024, 31(6): 842-847.
|
| 11. |
韋晨龍, 王昆. 經導管瓣中瓣置換術與二次外科主動脈瓣置換術在生物瓣衰敗患者中的應用效果與安全性比較[J]. 實用醫學雜志, 2025, 41(9): 1361-1367.Wei CL, Wang K. Comparison of the efficacy and safety of transcatheter valve replacement and secondary surgical aorticvalve replacement in patients with biological valve failure[J]. J Pract Med, 2025, 41(9): 1361-1367.
|
| 12. |
Bleiziffer S, Simonato M, Webb JG, et al. Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves[J]. Eur Heart J, 2020, 41(29): 2731-2742.
|
| 13. |
Malaisrie SC, Zajarias A, Leon MB, et al. Transcatheter aortic valve implantation for bioprosthetic valve failure: placement of aortic transcatheter valves 3 aortic valve-in-valve study[J/OL]. Struct Heart, 2022, 6(6): 100077. DOI: 10.1016/j.shj.2022.100077.
|
| 14. |
Praz F, Borger MA, Lanz J, et al. 2025 ESC/EACTS guidelines for the management of valvular heart disease: developed by the Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)[J/OL]. Eur Heart J, 2025, 1(1): xwag001. DOI: 10.1093/eurheart/ehaf194.
|
| 15. |
Seiffert M, Conradi L, Baldus S, et al. Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses[J]. J Thorac Cardiovasc Surg, 2012, 143(3): 617-624.
|
| 16. |
王墨揚, 周政, 牛冠男, 等. 經導管主動脈瓣置換術2023年度進展[J]. 中國介入心臟病學雜志, 2024, 32(1): 14-19.Wang MY, Zhou Z, Niu GN, et al. Progress of transcatheter aortic valve replacement in 2023[J]. Chin J Interv Cardiol, 2024, 32(1): 14-19.
|
| 17. |
Khan JM, Babaliaros VC, Greenbaum AB, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: results from the multicenter international BASILICA registry[J]. JACC Cardiovasc Interv, 2021, 14(9): 941-948.
|
| 18. |
Tzimas G, Akodad M, Meier D, et al. Predicted vs observed valve to coronary distance in valve-in-valve TAVR: a computed tomography study[J]. JACC Cardiovasc Interv, 2023, 16(16): 2021-2030.
|
| 19. |
Sá MP, Jacquemyn X, Simonato M, et al. Late survival after valve-in-valve transcatheter aortic valve implantation with balloon-versus self-expandable valves: meta-analysis of reconstructed time-to-event data[J]. Am J Cardiol, 2023, 209: 120-127.
|
| 20. |
Zhou J, Li Y, Zhang H. Case report: transapical transcatheter double valve-in-valve replacement of degenerated aortic and mitral bioprosthetic valves with limited radiopaque landmarks[J/OL]. Front Cardiovasc Med, 2022, 9: 1086457. DOI: 10.3389/fcvm.2022.1086457.
|
| 21. |
Magouliotis DE, Androutsopoulou V, Xanthopoulos A, et al. Optimizing aortic valve replacement through strategic upsizing: a modern framework for lifetime valve management[J/OL]. Diseases, 2026, 14(3): 103. DOI: 10.3390/diseases14030103.
|
| 22. |
Kamioka N, Ohno Y, Otsuka T, et al. Transcatheter aortic valve replacement for failed small surgical bioprostheses[J/OL]. JACC Asia, 2026. Epub ahead of print. DOI: 10.1016/j.jacasi.2026.01.034.
|